Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PETSied Kebir, Ulrich Herrlinger, Rolf Fimmers et al.|Clinical Cancer Research|2015Cited by 126
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Martin Glas, Gerrit H. Gielen et al.|Journal of Translational Medicine|2019Cited by 78
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastasesSied Kebir, Martin Glas, Laurèl Rauschenbach et al.|Neuro-Oncology|2016Cited by 73
Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade gliomaSied Kebir, Martin Glas, Zain Khurshid et al.|Oncotarget|2016Cited by 73
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human GlioblastomaRoman Reinartz, Björn Scheffler, Andreas Till et al.|Clinical Cancer Research|2016Cited by 72